Unfractionated heparin reversal: Difference between revisions

No edit summary
Line 1: Line 1:
==Background==
==Background==
*Managed according to clinical severity, NOT PTT value
*Managed according to clinical severity of bleeding, NOT PTT value
**Heparin-associated bleeding is not always reflected by a supratherapeutic PTT
**Heparin-associated bleeding is not always reflected by a supratherapeutic PTT


==Clinical Features==
==Indications==
 
*Significant bleeding while on [[heparin] drip
==Differential Diagnosis==
 
==Workup==


==Management==
==Management==
Line 17: Line 14:
**Give slowly over 1-3min; do not exceed 50mg in any 10 minute period
**Give slowly over 1-3min; do not exceed 50mg in any 10 minute period
**Because half-life is short (7 min) may require second treatment
**Because half-life is short (7 min) may require second treatment
*Massive bleed
*[[hemorrhage|Massive bleed]]
**Cryoprecipitate (10 U IV), then [[FFP]] (& platelets, aminocaproic acid infusion if nec)
**[[Cryoprecipitate]] (10 U IV), then [[FFP]] (& platelets, aminocaproic acid infusion if nec)


==Disposition==
==Disposition==

Revision as of 19:03, 1 October 2019

Background

  • Managed according to clinical severity of bleeding, NOT PTT value
    • Heparin-associated bleeding is not always reflected by a supratherapeutic PTT

Indications

  • Significant bleeding while on [[heparin] drip

Management

  • Stop transfusion
  • Observation alone may be appropriate in less severe cases
  • Protamine
    • Only indicated for major bleeding (0.2% of patients develop severe anaphylaxis)
    • Give 1mg IV for every 100 units of UFH infused in the prior 3hr
    • Give slowly over 1-3min; do not exceed 50mg in any 10 minute period
    • Because half-life is short (7 min) may require second treatment
  • Massive bleed

Disposition

See Also

External Links

References